NCT05360706 - Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Hemophilia B

Interventions

GENETIC

AAV5-hFIX

AAV5 containing a codon-optimized human factor IX gene

Trial Locations (6)

Vivantes Klinikum im Friedrichshain, Berlin

Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet, Frankfurt

Amsterdam UMC - Locatie AMC, Amsterdam

Groningen UMC, Groningen

Erasmus MC, Rotterdam

Universitair Medisch Centrum Utrecht, Utrecht